The trademark application EpyQ was filed by Ascend Advanced Therapies Ltd, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on August 22, 2024, and still open for oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Nucleic recombinant acids
Proteins for use in recombinant dna technology [other than for medical use]
Nucleic acid amplification reagents [other than for medical use]
Nucleic acid for use in nucleic acid amplification processes [other than for medical use]
Nucleic acids.
The mark was filed in class 5 with Nucleic acid sequences for medical and veterinary purposes.
The mark was filed in class 9 with following description of goods:
Gene amplifiers
DNA microarray
DNA microarrays.
The mark was filed in class 42 with Laboratory research in the field of gene expression and Biological cloning services..